Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by slowing digestion and reducing hunger signals in your brain. Finding your ideal dose is a gradual process—clinical trials show that doses ranging from 1.7 mg to 2.4 mg weekly produce the most consistent results, but your personal response matters more than the number on the label.

How Semaglutide Dosing Works for Weight Loss

Semaglutide treatment follows a structured titration schedule, meaning your dose increases in small steps every four weeks. You'll typically start at 0.25 mg to let your body adjust, then move to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg if tolerated. This gradual escalation reduces nausea and other side effects while building your body's sensitivity to the medication.

Your doctor monitors how you respond at each dose level before advancing you forward. Some people find their ideal weight loss happens at 1.7 mg weekly, while others need the full 2.4 mg dose. The goal is finding the lowest effective dose that produces meaningful results without unwanted effects—not automatically reaching the highest dose available.

Clinical evidence from the STEP trials showed that participants using semaglutide lost between 10% and 21% of their body weight over 68 weeks, depending on the dose they reached. However, the dose-response relationship isn't linear; jumping from 0.5 mg to 2.4 mg produces greater results than incremental increases at higher levels, suggesting a plateau effect.

Standard Semaglutide Dosing Schedule and Timeline

Week 1–4: You inject 0.25 mg once weekly. This starter dose allows your body to acclimate to the medication and helps identify any immediate sensitivities. Most people tolerate this dose well with minimal side effects.

Week 5–8: Your dose increases to 0.5 mg weekly. At this point, many patients begin noticing reduced appetite and early weight loss. Some people remain at this dose long-term if their weight loss goal is modest or if they experience significant side effects at higher doses.

Week 9–12: The dose moves to 1.0 mg weekly. This mid-range dose often produces noticeable appetite suppression and improved blood sugar control. Patients typically report strong satiety signals and reduced food cravings.

Personalization: Why Your Ideal Dose May Differ

Your genetics influence how your body responds to semaglutide, and PlexusDx uses precision testing to uncover individual peptide-pathway predispositions. The Precision Peptide Genetic Test identifies variations in GLP1R, GIPR, FTO, and MC4R genes that affect how strongly you respond to GLP-1 medications. Someone with a favorable GLP1R variant might achieve excellent results at 1.0 mg, while another person may require 2.4 mg for similar outcomes.

Body weight, age, and metabolic rate all influence dosing decisions. Heavier individuals sometimes benefit from higher doses, but research doesn't show a strict weight-to-dose relationship. Your gastric tolerance—how comfortable your stomach feels at each dose—often becomes the limiting factor before dose ceilings are reached.

Concurrent medications, particularly diabetes treatments, may alter how quickly your dose can increase. If you take insulin or other blood-sugar-lowering drugs, your doctor may recommend a slower titration schedule or closer glucose monitoring. Kidney function also plays a role; people with certain renal conditions may need dose adjustments or more frequent monitoring.

Semaglutide Dosing vs. Weight Loss Plateaus

Many people experience rapid weight loss in the first 12 weeks on semaglutide, then a plateau around week 16–20. This slowdown is normal and doesn't signal that the medication has stopped working. Your body reaches a new equilibrium where semaglutide prevents regain but doesn't produce additional loss. Increasing your dose at this point may restart loss, or you may have reached your personal optimal weight.

Research shows that continuing semaglutide long-term prevents weight regain far better than stopping after reaching a target weight. Participants who stayed on 2.4 mg semaglutide maintained 80% of their weight loss after one year, while those who discontinued regained significantly more. This suggests that maintenance dosing is an ongoing strategy, not a temporary intervention.

Cost Transparency: PlexusDx Semaglutide Pricing

PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies starting at $149 per month across all tiers—your dose may need to go up, but your price won't. This flat monthly price includes the medication, standard syringes, and injection supplies. No insurance is required, and HSA/FSA accounts cover PlexusDx treatment in most cases.

When you add the Precision Peptide Genetic Test ($99 as a one-time add-on after your first month), you gain insight into how your specific genetic profile influences semaglutide response. This personalized roadmap helps your provider optimize your dosing strategy from the start, potentially reducing trial-and-error adjustments and side effect experimentation. PlexusDx serves all 50 states with no membership fees or hidden charges.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What's the most common semaglutide dose people use for weight loss?

Most people reach either 1.7 mg or 2.4 mg weekly as their maintenance dose. Clinical trials showed the strongest results at 2.4 mg, but many individuals achieve meaningful weight loss at 1.7 mg with fewer side effects. Your ideal dose depends on your personal response, genetics, and tolerance.

How quickly should semaglutide doses increase?

Standard practice increases your dose every four weeks: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg. This 16-week titration allows your body to adapt and reduces nausea. Your provider may slow or speed this timeline based on how you respond and any side effects you experience.

Can I stay on a lower semaglutide dose permanently?

Yes. If you achieve your weight loss goal at 0.5 mg, 1.0 mg, or 1.7 mg and experience good tolerability, your doctor may recommend maintaining that dose indefinitely. The lowest effective dose is often the best dose—there's no clinical advantage to reaching maximum strength if lower doses work for you.

Why am I not losing weight at my current semaglutide dose?

Common reasons include early-stage plateau (normal after 12–16 weeks), insufficient time on your current dose, or the dose being too low for your individual metabolism. Genetic factors, thyroid function, and medication interactions also influence results. Discuss with your provider whether increasing your dose, adjusting lifestyle factors, or genetic testing (like PlexusDx's Precision Peptide Test) might help clarify the next step.

Does the PlexusDx Precision Peptide Genetic Test predict which semaglutide dose I'll need?

The Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants to reveal your genetic peptide-pathway profile. These insights help your provider understand your biological predisposition to GLP-1 medication response, potentially narrowing the dosing range that's most likely to work for you and reducing unnecessary side effect exposure.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves